Liver Neoplasms

• 

  Subject Areas on Research

  • 2002 E. Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis. 
  • 2017 Version of LI-RADS for CT and MR Imaging: An Update. 
  • 3D image guidance assisted identification of colorectal cancer liver metastases not seen on intraoperative ultrasound: results from a prospective trial. 
  • 4D liver tumor localization using cone-beam projections and a biomechanical model. 
  • A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603). 
  • A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer. 
  • A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients. 
  • A Rapidly Enlarging Müllerian-Derived Hepatic Adenomyoma Clinically Mimicking Hepatic Adenoma in a Pregnant Woman. 
  • A Simulation Paradigm for Evaluation of Subtle Liver Lesions at Pediatric CT: Performance and Confidence. 
  • A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine. 
  • A Technique for Generating Volumetric Cine-Magnetic Resonance Imaging. 
  • A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases. 
  • A case of curative-intent hepatectomy for colon cancer metastatic to the scapula and liver. 
  • A case report on metastatic ileal neuroendocrine neoplasm to the breast masquerading as primary breast cancer: A diagnostic challenge and management dilemma. 
  • A case-control method for assessing environmental risks from multiple industrial point sources. 
  • A comparison of antiangiogenic therapies for the prevention of liver metastases. 
  • A generic framework to simulate realistic lung, liver and renal pathologies in CT imaging. 
  • A hyperspectral imaging system for in vivo optical diagnostics. Hyperspectral imaging basic principles, instrumental systems, and applications of biomedical interest. 
  • A long-term experience with expansion of Milan criteria for liver transplant recipients. 
  • A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma. 
  • A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA) 
  • A niche role for cancer exosomes in metastasis. 
  • A pathological fracture and a solitary mass in the right clavicle: an unusual first presentation of HCC and the role of immunohistochemistry. 
  • A phase I-II trial of mitoxantrone by hepatic arterial infusion in patients with hepatocellular carcinoma or colorectal carcinoma metastatic to the liver. 
  • A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma. 
  • A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. 
  • A phase II study of docetaxel-irinotecan combination in advanced pancreatic cancer. 
  • A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases. 
  • A pressing situation. 
  • A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors. 
  • A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. 
  • A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases. 
  • A role for hepatic metastasectomy in stage IV melanoma and breast cancer: reestablishing the surgical modality. 
  • A segmental approach to computerized tomographic portography for hepatic resection. 
  • A singular value decomposition linear programming (SVDLP) optimization technique for circular cone based robotic radiotherapy. 
  • A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element. 
  • ACR Appropriateness Criteria® Chronic Liver Disease. 
  • ACR Appropriateness Criteria® Liver Lesion-Initial Characterization. 
  • ALPPS Procedure for Hepatocellular Carcinoma in Patients With Chronic Liver Disease: Revealing a Terra Incognita. 
  • ASO Author Reflections: Implementation of a New Hepatic Artery Infusion Program for Colorectal Liver Metastases is Safe, Feasible, and Effective. 
  • Ablation of perivascular hepatic malignant tumors with irreversible electroporation. 
  • Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma. 
  • Accelerating volumetric cine MRI (VC-MRI) using undersampling for real-time 3D target localization/tracking in radiation therapy: a feasibility study. 
  • Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review. 
  • Acoustic radiation force elasticity imaging in diagnostic ultrasound. 
  • Acoustic radiation force impulse imaging of the abdomen: demonstration of feasibility and utility. 
  • Acoustic radiation force impulse imaging of thermally- and chemically-induced lesions in soft tissues: preliminary ex vivo results. 
  • Acquisition of glutamine synthetase expression in human hepatocarcinogenesis: relation to disease recurrence and possible regulation by ubiquitin-dependent proteolysis. 
  • Acting in the face of uncertainty. 
  • Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis. 
  • Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma. 
  • Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? 
  • Acute and delayed bleeding requiring embolization after image-guided liver biopsy in patients with cancer. 
  • Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases. 
  • Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol. 
  • Adenocarcinoma of the liver without a detectable primary. 
  • Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: a meta-analysis. 
  • Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. 
  • Adoption of Splenic Enhancement to Time and Trigger the Late Hepatic Arterial Phase During MDCT of the Liver: Proof of Concept and Clinical Feasibility. 
  • Age differences in care practices and outcomes for hospitalized patients with cancer. 
  • Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis. 
  • Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. 
  • Alpha-glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3-CD56+ NK cells in vitro. 
  • An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo. 
  • An international survey on liver metastases radiotherapy. 
  • An update for LI-RADS: Version 2018. Why so soon after version 2017? 
  • Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma. 
  • Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis. 
  • Anesthetic management of a patient having a carcinoid syndrome. 
  • Annual literature review for clinical transplants 2005. 
  • Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. 
  • Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response. 
  • Antioxidants and prevention of gastrointestinal cancers. 
  • Apoptosis and cytokines in non-alcoholic steatohepatitis. 
  • Architectural pattern, tissue and cellular morphology in livers of fishes: relationship to experimentally-induced neoplastic responses. 
  • Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. 
  • Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1). 
  • Artificial intelligence in assessment of hepatocellular carcinoma treatment response. 
  • Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness. 
  • Assessing Textbook Outcomes Following Liver Surgery for Primary Liver Cancer Over a 12-Year Time Period at Major Hepatobiliary Centers. 
  • Associating liver partition and portal vein ligation for staged hepatectomy in patients with primary liver malignancies: A systematic review of the literature. 
  • Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. 
  • Association between tea consumption and risk of cancer: a prospective cohort study of 0.5 million Chinese adults. 
  • Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. 
  • Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study. 
  • Autophagic protein ULK1 regulates FOXM1 signalling in human hepatoma cells. 
  • Bevacizumab-associated fistula formation in postoperative colorectal cancer patients. 
  • Biases in the reporting of hepatocellular carcinoma tumor sizes on the liver transplant waiting list. 
  • Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors. 
  • Biochemical and histochemical properties of hepatic tumors of rainbow trout, Oncorhynchus mykiss. 
  • Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. 
  • Breath-hold three-dimensional CT of the liver with multi-detector row helical CT. 
  • Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma. 
  • Brief report: lymphoma of donor origin occurring in the porta hepatis of a transplanted liver. 
  • CD24 as a Novel Predictive Biomarker in Patients with Hepatocellular Carcinoma: Friend or Foe? 
  • CT arterial portography: causes of technical failure and variable liver enhancement. 
  • CT during arterial portography: diagnostic pitfalls. 
  • CT of fundoplication. 
  • CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. 
  • CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear. 
  • CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases. 
  • CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine. 
  • Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. 
  • Can MRI Features of Combined Hepatocellular Carcinoma-Intrahepatic Cholangiogarcinoma Help Predict Tumor Behavior Better than Histologic Findings? 
  • Can Realistic Liver Tissue Surrogates Accurately Quantify the Impact of Reduced-kV Imaging on Attenuation and Contrast of Parenchyma and Lesions? 
  • Carcinoid metastases to the liver: role of triple-phase helical CT. 
  • Carcinoid tumors of the gastrointestinal tract. A review and the Duke University institutional overview. 
  • Case 23-2005: a man with a mass in the liver. 
  • Case report. Intrabiliary colonic metastasis mimicking primary biliary neoplasia. 
  • Cases from the Osler Medical Service at Johns Hopkins University. 
  • Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology. 
  • Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. 
  • Central hepatectomy versus extended hepatectomy for liver malignancy: a matched cohort comparison. 
  • Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study. 
  • Challenges in screening for hepatocellular carcinoma in the glycogen storage disease type 1a population. 
  • Challenging choices: liver transplantation for hepatocellular carcinoma. 
  • Changes in the management of benign liver tumours: an analysis of 285 patients. 
  • Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium. 
  • Characterization and pathogenesis of anemia in glycogen storage disease type Ia and Ib. 
  • Characterization of Small Incidental Indeterminate Hypoattenuating Hepatic Lesions: Added Value of Single-Phase Contrast-Enhanced Dual-Energy CT Material Attenuation Analysis. 
  • Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing. 
  • Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis. 
  • Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer. 
  • Childhood hepatic mesenchymoma: successful treatment with surgery and multiple-agent chemotherapy. 
  • Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease. 
  • Cirrhosis of the liver in long-term marrow transplant survivors. 
  • Cisplatin and 5-fluorouracil infusion for metastatic colorectal carcinoma. Differences in survival in two patient groups with similar response rates. 
  • Clear cell sarcoma of the gastrointestinal tract after very low-dose therapeutic radiation therapy: a case report. 
  • Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors. 
  • Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. 
  • Clinical impact of an adaptive statistical iterative reconstruction algorithm for detection of hypervascular liver tumours using a low tube voltage, high tube current MDCT technique. 
  • Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis. 
  • Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence. 
  • Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein. 
  • Clinico-pathologic conference: 12-year-old girl with fatigue, anemia, weight loss, abdominal distention, and occasional nausea and vomiting. 
  • Clostridium septicum abscess in hepatic metastases: successful medical management. 
  • Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1alpha on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen therapy. 
  • Code Abdomen: An Assessment Coding Scheme for Abdominal Imaging Findings Possibly Representing Cancer. 
  • Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA. 
  • Colon cancer, version 3.2014. 
  • Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation. 
  • Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection. 
  • Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment. 
  • Combined CT arterial portography and CT hepatic angiography for evaluation of the hepatic resection candidate. Work in progress. 
  • Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases. 
  • Combined hepatocellular and cystadenocarcinoma presenting as a giant cyst of the liver--a case report. 
  • Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer. 
  • Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma. 
  • Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. 
  • Comparison of human and rat hepatocyte metabolism and mutagenic activation of 2-acetylaminofluorene. 
  • Comparison of three physiologically-based pharmacokinetic models for the prediction of contrast agent distribution measured by dynamic MR imaging. 
  • Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma. 
  • Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer. 
  • Computed tomography in the detection of abdominal metastases from malignant melanoma. 
  • Computed tomography of primary liver tumors in children. 
  • Concentration of Tc-99m methylenediphosphonate in hepatic metastases from squamous cell carcinoma. 
  • Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications. 
  • Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging. 
  • Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. 
  • Contemporary surgical options for metastatic colorectal cancer. 
  • Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution. 
  • Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. 
  • Cryosurgery after chemoembolization for hepatocellular carcinoma in patients with cirrhosis. 
  • Cryosurgical debulking of unresectable liver metastases for palliation of carcinoid syndrome. 
  • Current Approaches in the Management of Hepatic Adenomas. 
  • Current status of hepatic resection. 
  • Cytoablative therapy with combined resection and cryosurgery for limited bilobar hepatic colorectal metastases. 
  • Cytotoxicity phase of diethylnitrosamine-induced hepatic neoplasia in medaka. 
  • DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma. 
  • Decreased detection of hypovascular liver tumors with MDCT in obese patients: a phantom study. 
  • Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients. 
  • Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance. 
  • Desmoplastic small round cell tumor: using FISH as an ancillary technique to support cytologic diagnosis in an unusual case. 
  • Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases. 
  • Detection of Colorectal Hepatic Metastases Is Superior at Standard Radiation Dose CT versus Reduced Dose CT. 
  • Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy. 
  • Detection of focal hepatic masses: STIR MR vs. CT during arterial portography. 
  • Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT. 
  • Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue® low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI. 
  • Detection of liver masses with spiral computed tomography. 
  • Determining the optimal block margin on the planning target volume for extracranial stereotactic radiotherapy. 
  • Development and clinical evaluation of a three-dimensional cone-beam computed tomography estimation method using a deformation field map. 
  • Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma. 
  • Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. 
  • Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features. 
  • Diagnosis of metastatic malignant melanoma by fine needle aspiration biopsy: a clinical and pathologic correlation of 298 cases. 
  • Diagnostic approach to hepatic hemangiomas. 
  • Diagnostic criteria for degenerative, inflammatory, proliferative nonneoplastic and neoplastic liver lesions in medaka (Oryzias latipes): consensus of a National Toxicology Program Pathology Working Group. 
  • Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. 
  • Differences in Liver Imaging and Reporting Data System Categorization Between MRI and CT. 
  • Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines. 
  • Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors alpha and beta. 
  • Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways. 
  • Diffuse neonatal hemangiomatosis: imaging findings in two patients. 
  • Digital tomosynthesis for respiratory gated liver treatment: clinical feasibility for daily image guidance. 
  • Digital tomosynthesis with an on-board kilovoltage imaging device. 
  • Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. 
  • Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. 
  • Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma. 
  • Disappearing liver metastases: A systematic review of the current evidence. 
  • Discussion. 
  • Does the presence of coronary artery disease impact perioperative outcomes following partial hepatectomy? 
  • Donor-Derived Neuroendocrine Carcinoma Transmission to Two Kidney Transplant Recipients Demonstrated by Short Tandem Repeat Analysis: A Case Report. 
  • Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. 
  • Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. 
  • Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. 
  • Dual-Energy Multidetector Computed Tomography With Iodine Quantification in the Evaluation of Portal Vein Thrombosis: Is It Possible to Discard the Unenhanced Phase? 
  • Dual-Source Single-Energy Multidetector CT Used to Obtain Multiple Radiation Exposure Levels within the Same Patient: Phantom Development and Clinical Validation. 
  • Dual-energy MDCT in hypervascular liver tumors: effect of body size on selection of the optimal monochromatic energy level. 
  • Dual-phase 3D MDCT angiography for evaluation of the liver before hepatic resection. 
  • Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. 
  • E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. 
  • EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells. 
  • EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. 
  • Early trends in serum phosphate and creatinine levels are associated with mortality following major hepatectomy. 
  • Effect of Radiation Dose Reduction and Reconstruction Algorithm on Image Noise, Contrast, Resolution, and Detectability of Subtle Hypoattenuating Liver Lesions at Multidetector CT: Filtered Back Projection versus a Commercial Model-based Iterative Reconstruction Algorithm. 
  • Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis. 
  • Effect of a Noise-Optimized Second-Generation Monoenergetic Algorithm on Image Noise and Conspicuity of Hypervascular Liver Tumors: An In Vitro and In Vivo Study. 
  • Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. 
  • Effect of exposure to light-at-night on life span and spontaneous carcinogenesis in female CBA mice. 
  • Effect of growth conditions on the activity of ornithine decarboxylase in cultured hepatoma cells. I. Effect of amino acid supply. 
  • Effect of growth conditions on the activity of ornithine decarboxylase in cultured hepatoma cells. II. Effect of serum and insulin. 
  • Effect of growth conditions on the ornithine decarboxylase activity of rat hepatoma cells. 
  • Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. 
  • Effect of radiologists' experience with an adaptive statistical iterative reconstruction algorithm on detection of hypervascular liver lesions and perception of image quality. 
  • Effect of rapamycin alone and in combination with antiangiogenesis therapy in an orthotopic model of human pancreatic cancer. 
  • Effect of tumor size and tumor-to-liver contrast of hypovascular liver tumors on the diagnostic performance of hepatic CT imaging. 
  • Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosis. 
  • Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer. 
  • Effectiveness of Transarterial Embolization of Hepatocellular Carcinoma as a Bridge to Transplantation. 
  • Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation. 
  • Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study. 
  • Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. 
  • Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial. 
  • Electrophoretic analysis of four high molecular weight sialoglycoproteins produced by metastatic human colon carcinoma cells. 
  • Endometriosis of the liver containing mullerian adenosarcoma: case report. 
  • Endoscopic palliation of a biliocutaneous fistula with expandable metal stents. 
  • Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines. 
  • Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma. 
  • Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma. 
  • Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis. 
  • Epithelial-mesenchymal transitions and hepatocarcinogenesis. 
  • Estimating Tumor Growth Rates In Vivo. 
  • Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. 
  • Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells. 
  • Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm. 
  • Evaluation of a simpler technique for in-vivo labelling of red blood cells with 99mTc. 
  • Evaluation of dosimetric uncertainty caused by MR geometric distortion in MRI-based liver SBRT treatment planning. 
  • Evaluation of the liver for metastatic disease. 
  • Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review. 
  • Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases. 
  • Examining reoperation and readmission after hepatic surgery. 
  • Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation. 
  • Experience with more than 500 minimally invasive hepatic procedures. 
  • Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study. 
  • FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes. 
  • Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: Are checkpoint inhibitors safe for the pretransplant patient? 
  • Fine needle aspiration biopsy of the liver. 
  • Fine-needle aspiration of choroidal melanoma metastatic to the liver. 
  • Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab. 
  • Focal fatty infiltration: a cause of nontumorous defects in the left hepatic lobe during CT arterial portography. 
  • Focal hepatic lesions: detection by dynamic and delayed computed tomography versus short TE/TR spin echo and fast field echo magnetic resonance imaging. 
  • Focal intrahepatic extramedullary hematopoiesis mimicking neoplasm. 
  • Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? 
  • Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history. 
  • Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media. 
  • Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance. 
  • Fotemustine (S 10036) in the intra-arterial treatment of liver metastasis from malignant melanoma. A phase II Study. 
  • Four-dimensional image-based treatment planning: Target volume segmentation and dose calculation in the presence of respiratory motion. 
  • Four-dimensional magnetic resonance imaging using axial body area as respiratory surrogate: initial patient results. 
  • Frequency and predictors of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era. 
  • From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. 
  • Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis. 
  • Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver. 
  • Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening. 
  • Gastric adenocarcinoma: CT versus surgical staging. 
  • Gastroduodenal ulcerations in patients receiving selective hepatic artery infusion chemotherapy. 
  • Gastrohepatic Fistula After Y-90 Embolization of Hepatocellular Carcinoma. 
  • Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer. 
  • Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases. 
  • Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. 
  • Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition. 
  • Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors. 
  • Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes. 
  • Glutathione species and metabolomic prints in subjects with liver disease as biological markers for the detection of hepatocellular carcinoma. 
  • Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? 
  • Glycogen storage disease types I and II: treatment updates. 
  • Gray scale ultrasound and isotope scanning: complementary techniques for imaging the liver. 
  • Guidelines Insights: Hepatobiliary Cancers, Version 2.2019. 
  • HNF4α regulates sulfur amino acid metabolism and confers sensitivity to methionine restriction in liver cancer. 
  • Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer. 
  • Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein. 
  • Helical CT for detecting focal liver lesions in patients with breast carcinoma: comparison of noncontrast phase, hepatic arterial phase, and portal venous phase. 
  • Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients. 
  • Hepatic adenoma and focal nodular hyperplasia. 
  • Hepatic adenoma: MR appearance mimicking focal nodular hyperplasia. 
  • Hepatic adenoma: MR characteristics and correlation with pathologic findings. 
  • Hepatic angiomyolipoma and hepatic stellate cells share a similar gene expression profile. 
  • Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints. 
  • Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). 
  • Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease. 
  • Hepatic complications of obesity. 
  • Hepatic dynamic sequential CT: section enhancement profiles with a bolus of ionic and nonionic contrast agents. 
  • Hepatic focal nodular hyperplasia in infant antenatally exposed to steroids. 
  • Hepatic hemangiomas vs metastases: MR differentiation at 1.5 T. 
  • Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium. 
  • Hepatic imaging characteristics predict overall survival in hepatocellular carcinoma. 
  • Hepatic metastasis from neuroblastoma. 
  • Hepatic metastasis of a carotid body paraganglioma 5 years after resection of the primary tumor. 
  • Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract. 
  • Hepatic parenchymal enhancement during triple-phase helical CT: can it be used to predict which patients with breast cancer will develop hepatic metastases? 
  • Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4,152 resections for malignancy. 
  • Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence. 
  • Hepatic resection for hepatocellular carcinoma: do contemporary morbidity and mortality rates demand a transition to ablation as first-line treatment? 
  • Hepatic resection for metastatic cancer. 
  • Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. 
  • Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. 
  • Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. 
  • Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate. 
  • Hepatitis C. 
  • Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma. 
  • Hepatobiliary cystadenoma with mesenchymal stroma. 
  • Hepatobiliary phase MRI: impact on planning image-guided liver tumor ablations. 
  • Hepatobiliary phase hypointensity predicts progression to hepatocellular carcinoma for intermediate-high risk observations, but not time to progression. 
  • Hepatoblastoma diagnosed in infancy occurring in single-ventricle patients: a case series. 
  • Hepatocellular Carcinoma-The Influence of Immunoanatomy and the Role of Immunotherapy. 
  • Hepatocellular adenoma among adult survivors of childhood and young adult cancer. 
  • Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach. 
  • Hepatocellular carcinoma and model for end-stage liver disease exceptions: the more we understand, the more challenging the allocation gets. 
  • Hepatocellular carcinoma arising from ectopic liver tissue in the pancreas. 
  • Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results. 
  • Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout. 
  • Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. 
  • Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT. 
  • Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements. 
  • Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab. 
  • Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (≤2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up. 
  • Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. 
  • Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literature. 
  • Hepatocellular carcinoma. 
  • Hepatocellular carcinoma: clinical and angiographic findings and predictability for surgical resection. 
  • Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review With an Emphasis on Diagnostic Differentiation From Other T-Cell/Natural Killer-Cell Neoplasms. 
  • Hepatosplenic T-cell lymphoma with blastoid morphology in a patient with Crohn disease. 
  • Hepatosplenic T-cell lymphoma: an unusual case of a gamma delta T-cell lymphoma with a blast-like terminal transformation. 
  • Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity. 
  • High-depth sequencing of over 750 genes supports linear progression of primary tumors and metastases in most patients with liver-limited metastatic colorectal cancer. 
  • Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective. 
  • Histopathological prognostic factors influencing long-term prognosis after surgical resection for hepatic metastases from colorectal cancer. 
  • Hospital readmissions after liver surgery for metastatic colorectal cancer. 
  • How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine? 
  • How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma. 
  • Human mesenchymal stem cell and epithelial hepatic carcinoma cell lines in admixture: concurrent stimulation of cancer-associated fibroblasts and epithelial-to-mesenchymal transition markers. 
  • Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. 
  • Human xenograft-nude mouse model of adoptive immunotherapy with human melanoma-specific cytotoxic T-cells. 
  • Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma. 
  • Hypervascular liver tumors: low tube voltage, high tube current multi-detector row CT for enhanced detection--phantom study. 
  • Hypervascular liver tumors: low tube voltage, high tube current multidetector CT during late hepatic arterial phase for detection--initial clinical experience. 
  • I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score. 
  • Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers. 
  • Identification of driver genes in hepatocellular carcinoma by exome sequencing. 
  • Identification of liver cancer-specific aptamers using whole live cells. 
  • Ignore reality but not the consequences of its ignorance: Broaden guidelines in surgery of hepatocellular carcinoma. 
  • Imaging findings of liver resection using a bipolar radiofrequency electrosurgical device--initial observations. 
  • Imaging in Patients with Cirrhosis: Current Evidence. 
  • Imaging in the preoperative evaluation of adult liver-transplant candidates: goals, merits of various procedures, and recommendations. 
  • Imaging of patients with potentially resectable hepatic neoplasms. 
  • Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA. 
  • Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study. 
  • Impact of Peritoneal Metastasis on Survival of Patients With Small Intestinal Neuroendocrine Tumor. 
  • Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium. 
  • Impact of cancer center accreditation on outcomes of patients undergoing resection for hepatocellular carcinoma: A SEER-Medicare analysis. 
  • Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions. 
  • Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study. 
  • Impact of simultaneous diaphragm resection during hepatectomy for treatment of metastatic colorectal cancer. 
  • Impact of steatosis on perioperative outcome following hepatic resection. 
  • Impact of time-to-surgery on outcomes of patients undergoing curative-intent liver resection for BCLC-0, A and B hepatocellular carcinoma. 
  • Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein. 
  • Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver Metastases. 
  • Implementation of an Automated Radiology Recommendation-Tracking Engine for Abdominal Imaging Findings of Possible Cancer. 
  • Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. 
  • Improved contemporary outcomes of liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma. 
  • Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging. 
  • Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma. 
  • Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. 
  • In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneous. 
  • In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. 
  • In vivo guidance and assessment of liver radio-frequency ablation with acoustic radiation force elastography. 
  • In vivo selection of tumor-targeting RNA motifs. 
  • In vivo visualization of abdominal malignancies with acoustic radiation force elastography. 
  • In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors. 
  • Inadvertent pancreatic embolization as a complication of hepatic carcinoid treatment--computed tomography appearance. 
  • Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. 
  • Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver. 
  • Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. 
  • Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes. 
  • Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: experience with Cisplatinum-based chemoradiotherapy in 76 patients. 
  • Inhibition of the growth of human melanoma metastases in nude mice by melanoma-specific murine monoclonal antibody. 
  • Interreader Reliability of LI-RADS Version 2014 Algorithm and Imaging Features for Diagnosis of Hepatocellular Carcinoma: A Large International Multireader Study. 
  • Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial. 
  • Intrahepatic landscape of regulatory T-cell subsets in chronically HCV-infected patients with cirrhosis and HCC. 
  • Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma. 
  • Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation. 
  • Intrahepatic, extramedullary hematopoiesis mimicking hemangioma on technetium-99m red blood cell SPECT examination. 
  • Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis. 
  • Intrathoracic metastasis from an extrathoracic malignancy: a radiographic approach to patient evaluation. 
  • Investigation of sagittal image acquisition for 4D-MRI with body area as respiratory surrogate. 
  • Iron negative foci and nodules in safrole-exposed mouse liver made siderotic by iron-dextran injection. 
  • Irreversible electroporation (Nanoknife® treatment) in the field of hepatobiliary surgery: Current status and future perspectives. 
  • Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients. 
  • Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis. 
  • Is diaphragm motion a good surrogate for liver tumor motion? 
  • Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis? 
  • Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis? 
  • Is there a role for simultaneous hepatic and colorectal resections? A contemporary view from NSQIP. 
  • Isolated liver metastasis from a malignant phyllodes presenting with hemoperitoneum. 
  • Isolation of a transplantable cell line induced by the MC29 avian leukosis virus. 
  • Iterative reconstruction algorithm for abdominal multidetector CT at different tube voltages: assessment of diagnostic accuracy, image quality, and radiation dose in a phantom study. 
  • KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases. 
  • Kinetics of liver volume changes in the first year after portal vein embolization. 
  • LI-RADS 2017: An update. 
  • LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy. 
  • LI-RADS ancillary feature prediction of longitudinal category changes in LR-3 observations: an exploratory study. 
  • LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound. 
  • LI-RADS treatment response algorithm for detecting incomplete necrosis in hepatocellular carcinoma after locoregional treatment: a systematic review and meta-analysis using individual patient data. 
  • LI-RADS: Diagnostic Performance of Hepatobiliary Phase Hypointensity and Major Imaging Features of LR-3 and LR-4 Lesions Measuring 10-19 mm With Arterial Phase Hyperenhancement. 
  • LI-RADS: a glimpse into the future. 
  • Laparoscopic Hepatectomy for Hepatocellular Carcinoma: The Opportunities, the Challenges, and the Limitations. 
  • Laparoscopic liver surgery: a synopsis. 
  • Laparoscopic major hepatectomy: an evolution in standard of care. 
  • Laparoscopic staging for hepatobiliary carcinoma. 
  • Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review. 
  • Laparoscopic versus open liver resection: a matched-pair case control study. 
  • Laparoscopic versus open resection of colorectal liver metastasis. 
  • Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. 
  • Less is more: salvageability as the new creed in surgery of colorectal liver metastatic disease. 
  • Lipiodol: a potential direct surrogate for cone-beam computed tomography image guidance in radiotherapy of liver tumor. 
  • Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. 
  • Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations ≥ 10 mm at intermediate (LR-3) and high probability (LR-4) for hepatocellular carcinoma. 
  • Liver MR imaging: comparison of respiratory triggered fast spin echo with T2-weighted spin-echo and inversion recovery. 
  • Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. 
  • Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. 
  • Liver Tumor Microenvironment. 
  • Liver and abdominal screening in patients with cancer: CT versus MR imaging. 
  • Liver and intestine transplantation in the United States 1998-2007. 
  • Liver and intestine transplantation in the United States, 1997-2006. 
  • Liver and prostate adenocarcinoma: an "estrogen-free" environment? 
  • Liver angiomyolipomas: a clinical, radiologic, and pathologic analysis of 22 patients from a single center. 
  • Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway. 
  • Liver function tests: inadequate screening modality for detection of liver metastasis in head and neck carcinoma. 
  • Liver imaging with multidetector helical computed tomography. 
  • Liver metastases from breast cancer: long-term survival after curative resection. 
  • Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors. 
  • Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? 
  • Liver renewal: detecting misrepair and optimizing regeneration. 
  • Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. 
  • Liver transplantation for glycogen storage disease type Ia. 
  • Liver transplantation for hepatocellular carcinoma: Management after the transplant. 
  • Liver transplantation for liver malignancies in Wilson's disease: two novel cases. 
  • Liver transplantation for the treatment of hepatocellular carcinoma. 
  • Liver transplantation for unresectable colorectal liver metastases: A systematic review. 
  • Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review. 
  • Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies. 
  • Liver transplantation. 
  • Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice. 
  • Liver: single breath-hold dynamic subtraction CT with multi-detector row helical technology feasibility study. 
  • Living and deceased donor liver transplantation for unresectable hepatoblastoma at a single center. 
  • Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis. 
  • Living donor liver transplantation. 
  • Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria. 
  • Local control and results of Leksell Gamma Knife therapy for the treatment of uveal melanoma. 
  • Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. 
  • Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. 
  • Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up. 
  • Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy. 
  • Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer. 
  • Long-term outcomes following microwave ablation for liver malignancies. 
  • Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. 
  • Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals. 
  • Long-term survival after spontaneous rupture of a malignant rhabdoid tumor of the liver. 
  • Long-term trends in liver neoplasms in brown bullhead in the Buffalo River, New York, USA. 
  • Loss of BCAA Catabolism during Carcinogenesis Enhances mTORC1 Activity and Promotes Tumor Development and Progression. 
  • Loss of KAI1 expression in the progression of colorectal cancer. 
  • Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis. 
  • Low-tube-voltage, high-tube-current multidetector abdominal CT: improved image quality and decreased radiation dose with adaptive statistical iterative reconstruction algorithm--initial clinical experience. 
  • Luftsichel sign upperlobe collapse. 
  • Lysyl oxidase is essential for hypoxia-induced metastasis. 
  • MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing the growth of hepatic metastases. 
  • MR of focal liver lesions: comparison of breath-hold and non-breath-hold hybrid RARE and conventional spin-echo T2-weighted pulse sequences. 
  • MR-PET co-registration in upper abdominal imaging: quantitative comparison of two different T1-weighted gradient echo sequences: initial observations. 
  • MR-PET evaluation of 1-month post-ablation therapy for hepatocellular carcinoma: preliminary observations. 
  • MRI-based treatment planning for liver stereotactic body radiotherapy: validation of a deep learning-based synthetic CT generation method. 
  • MRI-based treatment planning for proton radiotherapy: dosimetric validation of a deep learning-based liver synthetic CT generation method. 
  • Macrophage migratory dysfunction in cancer. A mechanism for subversion of surveillance. 
  • Major liver resection in elderly patients: a multi-institutional analysis. 
  • Malignant biliary obstruction: efficacy of thin-section dynamic CT in determining resectability. 
  • Management implications and outcomes of LI-RADS-2, -3, -4, and -M category observations. 
  • Management of advanced neuroendocrine tumors with hepatic metastasis. 
  • Management of hepatocellular adenoma: comparison of resection, embolization and observation. 
  • Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic review. 
  • Mechanisms of disease progression in nonalcoholic fatty liver disease. 
  • Mechanistic insights of rapid liver regeneration after associating liver partition and portal vein ligation for stage hepatectomy. 
  • Menorrhagia in patients with type I glycogen storage disease. 
  • Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis. 
  • Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer. 
  • Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results. 
  • Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody. 
  • Metastatic lesions arising in a Riedel's lobe. Findings from a sulfur colloid liver-spleen scan. 
  • Metastatic potential of colon carcinoma. Expression of ABO/Lewis-related antigens. 
  • Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines. 
  • MicroRNA-375 Suppresses the Growth and Invasion of Fibrolamellar Carcinoma. 
  • Minimal Risk of Biliary Tract Complications, Including Hepatic Abscess, After Transarterial Embolization for Hepatocellular Carcinoma Using Concentrated Antibiotics Mixed with Particles. 
  • Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion. 
  • Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes. 
  • Mitochondrial transcription factor A induction by redox activation of nuclear respiratory factor 1. 
  • Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma. 
  • Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study. 
  • Multiphase multi-detector row computed tomography in the setting of chronic liver disease and orthotopic liver transplantation: can a series be eliminated in order to reduce radiation dose? 
  • Multiple endocrine neoplasia type 1 manifesting with chronic and persistent diarrhea. 
  • Murine bone marrow stromal cells pulsed with homologous tumor-derived exosomes inhibit proliferation of liver cancer cells. 
  • Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases. 
  • Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA. 
  • Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. 
  • NAFLD and extrahepatic cancers: have a look at the colon. 
  • NAFLD, NASH and liver cancer. 
  • NASH in HIV. 
  • NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. 
  • NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver Metastases. 
  • Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer. 
  • Necrolytic migratory erythema: association with neuroendocrine tumour with predominant insulin secretion. 
  • Negative biopsies, deadly disease: metastatic angiosarcoma. 
  • Neuroendocrine carcinomas of the gallbladder: Lessons learnt from cases at opposite ends of the spectrum. 
  • New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma. 
  • New observation of sialuria prompts detection of liver tumor in previously reported patient. 
  • Nitric oxide-dependent osteopontin expression induces metastatic behavior in HepG2 cells. 
  • Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases. 
  • Nodular regenerative hyperplasia in partial hepatectomy specimens. 
  • Non-Hodgkin lymphoma presenting with obstructive jaundice. 
  • Non-genetic risk factors and predicting efficacy for docetaxel--drug-induced liver injury among metastatic breast cancer patients. 
  • Non-hepatocellular carcinoma spinal metastases. 
  • Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern? 
  • Nonalcoholic Fatty Liver Disease and the Gut Microbiome. 
  • Not by blood alone: diagnosis of hemangiomas by fine-needle aspiration. 
  • Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes. 
  • Novikoff hepatoma deoxyribonucleic acid polymerase. Sensitivity of the beta-polymerase to sulfhydryl blocking agents. 
  • Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes. 
  • On confirmation bias in imaging research. 
  • Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma. 
  • Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis. 
  • Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. 
  • Operative morbidity and survival following hepatectomy for colorectal liver metastasis in octogenarians: a contemporary case matched series. 
  • Opportunities for targeted therapies in hepatocellular carcinoma. 
  • Opposite effects of lead on chemical carcinogenesis in kidney and liver of rats. 
  • Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI. 
  • Osteopontin regulates epithelial mesenchymal transition-associated growth of hepatocellular cancer in a mouse xenograft model. 
  • Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis. 
  • Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. 
  • Over-expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma. 
  • Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria. 
  • Overall survival or other clinical benefits from adjuvant selective intraarterial chemotherapy in patients undergoing curative liver resection for metastatic colorectal tumor. 
  • Overexpression of caspase-3 in hepatocellular carcinomas. 
  • Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma. 
  • Overview of stereotactic body radiotherapy and the nursing role. 
  • Oxygen flux analysis to understand the biological function of sirtuins. 
  • PET/CT mediastinal and liver FDG uptake: effects of biological and procedural factors. 
  • PGC-1beta in the regulation of hepatic glucose and energy metabolism. 
  • Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. 
  • Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy. 
  • Paracrine Hedgehog signaling drives metabolic changes in hepatocellular carcinoma. 
  • Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review. 
  • Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes. 
  • Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. 
  • Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome. 
  • Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. 
  • Pathology and imaging of hepatocellular neoplasms: are findings from Asian populations applicable to non-Asian groups? 
  • Patient Triage for Resection of Metastatic Colorectal Cancer to the Liver: Can We Do Better Using MRI? 
  • Patient and tumor characteristics predictive of an elevated hepatopulmonary shunt fraction before radioembolization of hepatic tumors. 
  • Patient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconception. 
  • Patterns of failure after pancreaticoduodenectomy for ampullary carcinoma. 
  • Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer. 
  • Patterns of recurrence after ablation of colorectal cancer liver metastases. 
  • Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer. 
  • Percutaneous transhepatic choledochocholedochostomy in the management of the postoperative patient. 
  • Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis. 
  • Perioperative and oncologic outcomes of minimally invasive liver resection for colorectal metastases: A case-control study of 130 patients. 
  • Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases. 
  • Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. 
  • Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer. 
  • Personalized treatment in patients with colorectal liver metastases. 
  • Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate. 
  • Pharmacokinetics of combined gene therapy expressing constitutive human GM-CSF and hyperthermia-regulated human IL-12. 
  • Phase 1 study of N(1),N(11)‑diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma. 
  • Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma. 
  • Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. 
  • Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM). 
  • Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib. 
  • Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma. 
  • Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. 
  • Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma. 
  • Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy. 
  • Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma. 
  • Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers. 
  • Physician-assisted suicide and advance directives concerning life support. 
  • Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma. 
  • Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. 
  • Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases. 
  • Post transfusion non-cardiogenic pulmonary edema in a patient with chemotherapy-related hemolytic uremic syndrome. 
  • Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors. 
  • Predicting real-time 3D deformation field maps (DFM) based on volumetric cine MRI (VC-MRI) and artificial neural networks for on-board 4D target tracking: a feasibility study. 
  • Predicting recurrence patterns after resection of hepatocellular cancer. 
  • Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort. 
  • Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases. 
  • Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. 
  • Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma. 
  • Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma. 
  • Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis. 
  • Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation. 
  • Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. 
  • Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience. 
  • Preoperative localization of focal liver lesions to specific liver segments: utility of CT during arterial portography. 
  • Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer. 
  • Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis. 
  • Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort. 
  • Primary Hepatic Lymphoma Complicated by a Hepatic Inflammatory Pseudotumor and Tumor-Forming Pancreatitis. 
  • Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival. 
  • Primary high-grade neuroendocrine carcinoma emerging from an adenomatous polyp in the setting of familial adenomatous polyposis. 
  • Primary leiomyoma of the liver. 
  • Primary malignant fibrous histiocytoma of the liver MRI findings. 
  • Problems for risk assessment of endocrine-active estrogenic compounds. 
  • Proceed with caution: liver transplantation for metastatic neuroendocrine tumors. 
  • Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification. 
  • Prognostic factors in the initial response to therapy by patients with advanced breast cancer. 
  • Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma. 
  • Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features. 
  • Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis. 
  • Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma. 
  • Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480. 
  • Prognostic significance of primary tumor sidedness in patients undergoing liver resection for metastatic colorectal cancer. 
  • Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement. 
  • Program death-1 immune checkpoint and tumor microenvironment in malignant liver tumors. 
  • Progression of Treated versus Untreated Liver Imaging Reporting and Data System Category 4 Masses after Transcatheter Arterial Embolization Therapy. 
  • Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma. 
  • Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases. 
  • Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential. 
  • Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma. 
  • Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions. 
  • Quantitative Imaging Features and Postoperative Hepatic Insufficiency: A Multi-Institutional Expanded Cohort. 
  • Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases. 
  • Quantitative mass spectrometry of DENV-2 RNA-interacting proteins reveals that the DEAD-box RNA helicase DDX6 binds the DB1 and DB2 3' UTR structures. 
  • RNA stability regulates differential expression of the metastasis protein, osteopontin, in hepatocellular cancer. 
  • Radiation-associated liver injury. 
  • Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description. 
  • Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication. 
  • Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin. 
  • Radiofrequency ablation of liver tumors: influence of technique and tumor size. 
  • Radiologic-pathologic correlation of uncommon mesenchymal liver tumors. 
  • Radiological evaluation of metastases to the liver: The Emory experience. 
  • Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone. 
  • Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. 
  • Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed. 
  • Rapid degradation of puromycyl peptides in hepatoma cells and reticulocytes. 
  • Rates of surveillance and management of hepatocellular carcinoma in patients evaluated at a liver transplant center. 
  • Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases. 
  • Reassessing hepatocellular carcinoma staging in a changing patient population. 
  • Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii. 
  • Rectal cancer: presentation with metastatic and locally advanced disease. American College of Radiology. ACR Appropriateness Criteria. 
  • Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection. 
  • Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria. 
  • Recurrence patterns following irreversible electroporation for hepatic malignancies. 
  • Recurrent Burkitt's lymphoma mimicking toxic veno-occlusive disease of the liver. 
  • Recurrent tumor after resection of hepatic metastases from colorectal carcinoma: location and time of discovery as determined by CT. 
  • Referring Provider Perceptions of Standardized Reporting for Possible Abdominal Cancer. 
  • Refractory myasthenia gravis exacerbation triggered By pembrolizumab. 
  • Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. 
  • Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al. 
  • Reproducibility of CT Radiomic Features within the Same Patient: Influence of Radiation Dose and CT Reconstruction Settings. 
  • Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? 
  • Resection of adrenocortical carcinoma liver metastasis: is it justified? 
  • Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. 
  • Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis. 
  • Residual motion mitigation in scanned carbon ion beam therapy of liver tumors using enlarged pencil beam overlap. 
  • Resolution of hepatic encephalopathy following hepatic artery embolization in a patient with well-differentiated neuroendocrine tumor metastatic to the liver. 
  • Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases. 
  • Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer. 
  • Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy. 
  • Ring finger protein 121 is a potent regulator of adeno-associated viral genome transcription. 
  • Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration 
  • Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. 
  • Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis. 
  • Risk of occult irresectable disease at liver resection for hepatic colorectal cancer metastases: a contemporary analysis. 
  • Robotic Liver Resection: A Case-Matched Comparison. 
  • Role of computed tomography in screening for hepatocellular carcinoma in patients with cirrhosis. 
  • Role of exosomes in treatment of hepatocellular carcinoma. 
  • Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety). 
  • Safety and oncologic outcomes of robotic liver resections: A systematic review. 
  • Safety of Percutaneous Biopsy for Hepatic Angiosarcoma: Results of a Multicenter Korean Survey. 
  • Scintigraphy, ultrasound and CT scanning of the liver. 
  • Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma. 
  • Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps. 
  • Short-Term Risk of Performing Concurrent Procedures with Hepatic Artery Infusion Pump Placement. 
  • Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative. 
  • Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. 
  • Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. 
  • Single-Cell RNA Sequencing Identifies Yes-Associated Protein 1-Dependent Hepatic Mesothelial Progenitors in Fibrolamellar Carcinoma. 
  • Single-incision laparoscopic liver resection. 
  • Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation. 
  • Solid pseudopapillary tumors of the pancreas. Clinical features, surgical outcomes, and long-term survival in 45 consecutive patients from a single center. 
  • Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model. 
  • Sorting multiple classes in multi-dimensional ROC analysis: parametric and nonparametric approaches. 
  • Spectrum of Pitfalls, Pseudolesions, and Potential Misdiagnoses in Cirrhosis. 
  • Spindle-cell lesions of the liver: diagnosis by fine-needle aspiration biopsy. 
  • Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. 
  • State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials-A Multidisciplinary Approach. 
  • Stemming the tide of hepatitis B virus related hepatocellular carcinoma? 
  • Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities. 
  • Stereotactic Body Radiation Therapy-Induced Abscopal Effect on Hepatocellular Carcinoma After Treatment for Lung Cancer: A Case Report. 
  • Subcentimeter hypervascular nodule with typical imaging findings of hepatocellular carcinoma in patients with history of hepatocellular carcinoma: natural course on serial gadoxetic acid-enhanced MRI and diffusion-weighted imaging. 
  • Successful treatment of immune thrombocytopenic purpura with anti-D antibody following a cadaveric liver transplant for hepatoblastoma. 
  • Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging. 
  • Surgery or ablative radiotherapy for breast cancer oligometastases. 
  • Surgical clearance for the patient with chronic liver disease. 
  • Surgical options for advanced/metastatic gastrointestinal stromal tumors. 
  • Surgical resection for benign and malignant liver disease. 
  • Surgical resection for small hepatocellular carcinoma. 
  • Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis. 
  • Surveillance for hepatocellular carcinoma. 
  • Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. 
  • Sustained expression of human factor VIII in mice using a parvovirus-based vector. 
  • Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management? 
  • Synchronous colorectal liver metastases: the "surgeon as oncologist" perspective. 
  • Synchronous resection of esophageal cancer and other organ malignancies: A systematic review. 
  • Synchronous resection of primary and liver metastases for neuroendocrine tumors. 
  • T2-Weighted Liver MRI Using the MultiVane Technique at 3T: Comparison with Conventional T2-Weighted MRI. 
  • TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. 
  • Targeting Histone Deacetylase 6 Reprograms Interleukin-17-Producing Helper T Cell Pathogenicity and Facilitates Immunotherapies for Hepatocellular Carcinoma. 
  • Targeting Neoantigens in Hepatocellular Carcinoma for Immunotherapy: A Futile Strategy? 
  • Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies. 
  • Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. 
  • Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. 
  • Technique for MR imaging of the liver. 
  • Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis. 
  • Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial. 
  • The ALPPS procedure as a novel "liver-first" approach in treating liver metastases of colon cancer: the first experience in Greek Cypriot area. 
  • The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. 
  • The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases. 
  • The Epidemiology, Staging and Outcomes of Sarcomatoid Hepatocellular Carcinoma: A SEER Population Analysis. 
  • The Genetic Basis of Hepatosplenic T-cell Lymphoma. 
  • The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial. 
  • The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer. 
  • The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma. 
  • The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer. 
  • The Prognosis of Hepatocellular Carcinoma Treated with Sorafenib in Combination with TACE. 
  • The Role of Angiogenesis in Hepatocellular Carcinoma. 
  • The Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis. 
  • The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer. 
  • The adventures of sonic hedgehog in development and repair. II. Sonic hedgehog and liver development, inflammation, and cancer. 
  • The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1. 
  • The approach to the patient with single and multiple liver metastases, pulmonary metastases, and intra-abdominal metastases from colorectal carcinoma. 
  • The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. 
  • The diagnostic accuracy/efficacy of MRI in differentiating hepatic hemangiomas from metastatic colorectal/breast carcinoma: a multiple reader ROC analysis using a jackknife technique. 
  • The effect of Guidelines in surgical decision making: The paradigm of hepatocellular carcinoma. 
  • The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance). 
  • The effect of protein nutrition on host and tumor metabolism. 
  • The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma. 
  • The effects of hepatic cryosurgery on tumor growth in the liver. 
  • The efficacy of anti-PD-1 agents in acral and mucosal melanoma. 
  • The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. 
  • The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study. 
  • The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs. 
  • The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. 
  • The hedgehog pathway in nonalcoholic fatty liver disease. 
  • The impact of respiratory motion and treatment technique on stereotactic body radiation therapy for liver cancer. 
  • The induction of ornithine decarboxylase in cultured hepatoma cells. 
  • The mRECIST Classification Provides Insight into Tumor Biology for Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation. 
  • The management of variant arterial anatomy during hepatic arterial infusion pump placement. 
  • The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma. 
  • The natural history of hepatitis C viral infection. 
  • The potential role of preoperative portal vein embolization for the prevention of small-for-size syndrome. 
  • The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. 
  • The role of Hedgehog signaling in fibrogenic liver repair. 
  • The role of external beam radiotherapy in the treatment of hepatocellular cancer. 
  • The struggle for intensive care coverage of patients with hepatobiliary malignancies in Greece: Patients are not numbers. 
  • The subcellular localization of syntaxin 17 varies among different cell types and is altered in some malignant cells. 
  • The unique identity of rat hepatoma phenylalanine hydroxylase. 
  • The use of ultrasound to enhance the diagnostic utility of the equivocal liver scintigraph. 
  • The utility of micro-CT and MRI in the assessment of longitudinal growth of liver metastases in a preclinical model of colon carcinoma. 
  • Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation-part one: curative intention. 
  • Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation. Part two: noncurative intention. 
  • Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation. 
  • Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation. 
  • Timing Is Everything. 
  • Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis. 
  • To ablate or not to ablate?: that is the question. 
  • Towards a definite mouse model of NAFLD. 
  • Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism. 
  • Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. 
  • Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times. 
  • Transplanted carcinoma in an immunosuppressed patient. 
  • Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results? 
  • Treatment of advanced colorectal cancer. 
  • Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease. 
  • Treatment of giant hemangiomas of the liver by enucleation. 
  • Treatment of hepatic metastases. 
  • Treatment of human melanoma hepatic metastases in nude mice with human cytotoxic T lymphocytes. 
  • Treatment of primary liver tumors with Yttrium-90 microspheres (TheraSphere) in high risk patients: analysis of survival and toxicities. 
  • Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump. 
  • Trends and outcomes of simultaneous versus staged resection of synchronous colorectal cancer and colorectal liver metastases. 
  • Trends in the Mortality of Hepatocellular Carcinoma in the United States. 
  • Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases. 
  • Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome. 
  • U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia. 
  • Underlying potential: cellular and molecular determinants of adult liver repair. 
  • Understanding Factors Governing Distribution Volume of Ethyl Cellulose-Ethanol to Optimize Ablative Therapy in the Liver. 
  • Unknown primary tumors metastatic to liver. 
  • Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization. 
  • Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication. 
  • Update on Surgical Management of Small Bowel Neuroendocrine Tumors. 
  • Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy. 
  • Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer. 
  • Updates and Critical Insights on Glissonian Approach in Liver Surgery. 
  • Use of bioluminescence imaging to detect enhanced hepatic and systemic tumor growth following partial hepatectomy in mice. 
  • Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice. 
  • Use of intraoperative ablation as an adjunct to surgical resection in the treatment of recurrent colorectal liver metastases. 
  • User and system pitfalls in liver imaging with LI-RADS. 
  • Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases. 
  • Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma. 
  • Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines. 
  • V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials. 
  • Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database. 
  • Validation of lesion simulations in clinical CT data for anonymized chest and abdominal CT databases. 
  • Value of PET/CT in the management of liver metastases, part 1. 
  • Value of PET/CT in the management of primary hepatobiliary tumors, part 2. 
  • Variability of quantitative measurements of metastatic liver lesions: a multi-radiation-dose-level and multi-reader comparison. 
  • Vascular inflow control during hemi-hepatectomy: a comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation. 
  • Vascular invasion is a prognostic indicator in hepatoblastoma. 
  • Vector-related tumorigenesis not found in ornithine transcarbamylase-deficient mice. 
  • Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma. 
  • Vitamins E and K induce aryl hydrocarbon hydroxylase activity in human cell cultures. 
  • We've come a long way, baby! 
  • White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI. 
  • Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma. 
  • With proper imaging technique, is it still necessary to obtain images of the liver before administering contrast material in patients with known tumors who can have hypervascular liver metastases? 
  • Without victory there is no survival: transarterial lipiodol chemoembolization and hepatocellular carcinoma. 
  • Yttrium-90 radioembolization of malignant tumors of the liver: gallbladder effects. 
  • [Comparison and analysis of clinicopathology of lung cancer between 1980s and 1990s in the Shenyang area (1,224 cases)]. 
  • [Intraportal injection of specific monoclonal antibody in nude mice with liver metastasis]. 
  • [Malignant melanoma: hepatic intra-arterial chemotherapy]. 
  • c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival. 
  • p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene. 
• 

  Keywords of People

  • Abbruzzese, James, D. C. I. Distinguished Professor of Medical Oncology, Medicine, Medical Oncology
  • Buckley, Anne Frances, Assistant Professor of Pathology, Pathology
  • Choi, Steven Sok, Associate Professor of Medicine, Medicine, Gastroenterology
  • Colsher, James George, Adjunct Assistant Professor in the Department of Radiology, Radiology
  • Hirschey, Matthew, Associate Professor of Medicine, Pharmacology & Cancer Biology
  • Hogan, Brigid L. M., George Barth Geller Distinguished Professor for Research in Molecular Biology, Cell Biology
  • Jowell, Paul Simon, Professor of Medicine, Medicine, Gastroenterology
  • Sullivan, Daniel Carl, Professor Emeritus of Radiology, Radiology
  • Uronis, Hope Elizabeth, Associate Professor of Medicine, Medicine, Medical Oncology